Characteristics | |
---|---|
Age in years, mean (SD) | 82.5 (± 6.8) |
Woman, n (%) | 59 (49%) |
Cohabiting with family or others, n (%) | 62 (51%) |
Co-morbidities | n (%) |
Hypertension | 76 (63%) |
MI / ischemic heart disease | 62 (51%) |
Atrial fibrillation | 59 (49%) |
Diabetes without complications | 26 (22%) |
Stroke | 24 (20%) |
COPD | 20 (17%) |
Renal failure | 18 (15%) |
Malignancy | 16 (13%) |
Other | 14 (12%) |
Period of time since diagnosed | n (%) |
< 1 year | 44 (36%) |
1–5 years | 33 (27%) |
> 5 years | 38 (31%) |
Pharmacological treatment at discharge | n (%) |
ACEI/ARB | 91 (75%) |
MRA | 34 (28%) |
Beta-blocker | 100 (83%) |
Total number of medication at discharge mean (SD) | 11.58 (± 4.37) |